Respiratory Distress Syndrome clinical trials

Explore recruiting respiratory distress syndrome clinical trials.

Recruiting respiratory distress syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Respiratory Distress Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of intravenous metoprolol in patients with Acute Respiratory Distress Syndrome (ARDS).

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Potential of FX06 to improve disease severity in Acute Respiratory Distress Syndrome patients (Ixion 2.0)

Spain, France, Romania, Germany, Lithuania

Therapeutic exploratory (Phase II) EU CTIS Study details

APROTININ TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Impact of post-Acute respiratory distress syndrome COVID sedation on late neuroinflammation (PET-DEXDOCOVID)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Duration of Surfactant administration and impact on Stabilisation of vital parameters in very preterm neonates: 1 minute versus 5 minutes – a prospective randomised-controlled phase IV trial

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Phase 2, proof-of-concept, randomized, double-blinded, placebo-controlled, multicenter study to assess efficacy and safety of reparixin as add-on therapy to standard of care in adult patients with Acute Respiratory Distress Syndrome (RESPIRATIO)

Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Respiratory Distress Syndrome trials by city

Respiratory Distress Syndrome in Toronto Respiratory Distress Syndrome in Vancouver Respiratory Distress Syndrome in Montreal Respiratory Distress Syndrome in Calgary Respiratory Distress Syndrome in Edmonton Respiratory Distress Syndrome in Ottawa Respiratory Distress Syndrome in Winnipeg Respiratory Distress Syndrome in Quebec City Respiratory Distress Syndrome in Hamilton Respiratory Distress Syndrome in Kitchener Respiratory Distress Syndrome in London Respiratory Distress Syndrome in Halifax Respiratory Distress Syndrome in New York Respiratory Distress Syndrome in Los Angeles Respiratory Distress Syndrome in Chicago Respiratory Distress Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease